NFA
SRNE

Nationwide Fund Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Nationwide Fund Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,417
Closed -$57K – 3289
2017
Q1 		$57K Sell
14,417
-2,037
-12% -$10.2K ﹤0.01% 2963
2016
Q4 		$81K Sell
16,454
-1,893
-10% -$11.4K ﹤0.01% 2927
2016
Q3 		$142K Hold
18,347
– – ﹤0.01% 2782
2016
Q2 		$103K Hold
18,347
– – ﹤0.01% 2907
2016
Q1 		$99K Hold
18,347
– – ﹤0.01% 2823
2015
Q4 		$160K Hold
18,347
– – ﹤0.01% 2656
2015
Q3 		$154K Hold
18,347
– – ﹤0.01% 2701
2015
Q2 		$323K Buy
+18,347
New +$236K ﹤0.01% 2478

Other funds holding SRNE

WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return